Group 1 - The medical device ETF (562600) experienced a decline of 1.70% as of the market close on October 17, 2023, despite some holdings like TransMedics, Hotgen Biotech, and Novogene showing gains of 4.45%, 2.80%, and 2.25% respectively [1] - According to the National Medical Products Administration, a total of 348 medical device products were approved for registration by September 2025, including 276 domestic Class III devices, 34 imported Class III devices, 36 imported Class II devices, and 2 devices from Hong Kong, Macau, and Taiwan [1] - CITIC Securities believes that the medical device sector, which has seen a continuous decline over the past four years, is now experiencing a rebound, with expectations for performance turning points in the second half of this year to next year due to improved procurement policies, better bidding data, and decreasing channel inventory [1] Group 2 - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device industry, tracking the CSI All Share Medical Device Index, which includes 100 representative listed companies in medical devices, medical services, and medical information technology [2] - The medical device sector constitutes a significant 89.34% of the index, indicating a high concentration that allows for precise capture of the sector's growth dividends [2] - As of October 10, 2023, the top ten holdings of the medical device ETF (562600) included Mindray Medical and United Imaging Healthcare, which together accounted for 23.81% of the ETF [2]